Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-10-29

Clinical Trial Update: A Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia [Phase 2]

View source ↗

Summary

This document provides a status update on a Phase 2 clinical trial evaluating ORX750 for narcolepsy type 1, narcolepsy type 2, and idiopathic hypersomnia, which…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ORX750

Snippet

Sponsor: Centessa Pharmaceuticals (UK) Limited | Conditions: Narcolepsy Type 1, Narcolepsy Type 2 | Phase 2 | Status: RECRUITING